Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Diabetes
•
Endocrinology
Should short courses of insulin be considered for steroid-induced hyperglycemia in patients with pre-diabetes or mild diabetes well controlled on oral therapy?
Related Questions
Do you use the homeostatic model assessment (HOMA) to assess for insulin resistance and change your clinical management of patients?
What work-up should be considered in patients with significantly worsening A1c despite steady diet, lifestyle, and medication adherence?
Should we recommend SGLT2i initiation at discharge to all patients hospitalized with acute myocardial infarction?
Will Omnipod 5 work well in patients receiving bursts of corticosteroids or in those on hemodialysis?
Does your decision to start or continue Ozempic therapy in patients with diabetic retinopathy depend on the severity of the retinopathy?
What are the potential causes for significant discrepancies between predicted A1c by Dexcom CGM and standard serum A1c by lab draw?
Do you recommend neuromodulation treatments with an implantable device for patients with chronic painful diabetic neuropathy who have not responded to common oral therapies such as Gabapentin and Amitriptyline?
What is your approach to addressing severe dawn phenomenon in your patients with diabetes?
Which patient population would most benefit from inhaled insulin (Afrezza)?
How do you adjust your management strategy to address the unique needs of anuric end-stage kidney disease patients when treating diabetic ketoacidosis?